Encompass Health Co. (NYSE:EHC) Shares Bought by MGO One Seven LLC

by · The Markets Daily

MGO One Seven LLC grew its holdings in Encompass Health Co. (NYSE:EHC – Free Report) by 17.3% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 4,555 shares of the company’s stock after buying an additional 673 shares during the period. MGO One Seven LLC’s holdings in Encompass Health were worth $421,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Price T Rowe Associates Inc. MD lifted its stake in Encompass Health by 22.9% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 1,610,669 shares of the company’s stock worth $148,746,000 after purchasing an additional 300,386 shares in the last quarter. Dark Forest Capital Management LP lifted its position in Encompass Health by 16.0% during the fourth quarter. Dark Forest Capital Management LP now owns 7,305 shares of the company’s stock worth $675,000 after buying an additional 1,009 shares in the last quarter. Hsbc Holdings PLC grew its holdings in Encompass Health by 20.4% in the 4th quarter. Hsbc Holdings PLC now owns 41,722 shares of the company’s stock valued at $3,861,000 after buying an additional 7,061 shares in the last quarter. Stifel Financial Corp increased its stake in shares of Encompass Health by 6.4% in the 4th quarter. Stifel Financial Corp now owns 64,870 shares of the company’s stock worth $5,991,000 after acquiring an additional 3,886 shares during the last quarter. Finally, Tower Research Capital LLC TRC raised its holdings in shares of Encompass Health by 139.3% during the 4th quarter. Tower Research Capital LLC TRC now owns 10,598 shares of the company’s stock worth $979,000 after acquiring an additional 6,169 shares during the period. 97.25% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the stock. Royal Bank of Canada restated an “outperform” rating and set a $110.00 price objective on shares of Encompass Health in a research report on Tuesday, February 11th. Barclays lifted their price target on shares of Encompass Health from $118.00 to $129.00 and gave the company an “overweight” rating in a research report on Friday. KeyCorp increased their price objective on Encompass Health from $120.00 to $122.00 and gave the stock an “overweight” rating in a research report on Friday. StockNews.com upgraded Encompass Health from a “hold” rating to a “buy” rating in a research report on Friday. Finally, William Blair reissued an “outperform” rating on shares of Encompass Health in a research report on Friday, February 7th. Nine equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, Encompass Health has a consensus rating of “Buy” and an average price target of $113.14.

Get Our Latest Research Report on EHC

Insider Transactions at Encompass Health

In related news, CAO Andrew L. Price sold 5,042 shares of Encompass Health stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total value of $495,578.18. Following the completion of the transaction, the chief accounting officer now owns 69,164 shares in the company, valued at $6,798,129.56. The trade was a 6.79 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 2.10% of the company’s stock.

Encompass Health Trading Up 11.8 %

NYSE EHC opened at $113.33 on Monday. Encompass Health Co. has a one year low of $82.38 and a one year high of $114.38. The firm has a 50 day simple moving average of $100.08 and a 200-day simple moving average of $98.57. The firm has a market cap of $11.41 billion, a price-to-earnings ratio of 25.41, a PEG ratio of 2.31 and a beta of 0.87. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.04 and a current ratio of 1.05.

Encompass Health (NYSE:EHC – Get Free Report) last posted its quarterly earnings results on Thursday, April 24th. The company reported $1.37 EPS for the quarter, topping the consensus estimate of $1.19 by $0.18. The business had revenue of $1.46 billion during the quarter, compared to the consensus estimate of $1.43 billion. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. Equities research analysts anticipate that Encompass Health Co. will post 4.8 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st were paid a $0.17 dividend. This represents a $0.68 annualized dividend and a dividend yield of 0.60%. The ex-dividend date was Tuesday, April 1st. Encompass Health’s payout ratio is presently 15.25%.

About Encompass Health

(Free Report)

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

Further Reading

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Co. (NYSE:EHC – Free Report).